Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes
Michael Wulfert(Heinrich Heine University Düsseldorf), Norbert Gattermann(Institute of Biomedical Science), Christoph Tapprich(Johnson & Johnson (Germany)), Rainer Haas(Beth Israel Deaconess Medical Center), Ulrich Germing(Düsseldorf University Hospital), David Bowen(University of Tennessee Health Science Center), Anna C. Küpper(Heinrich Heine University Düsseldorf), Sylvia S. Bottomley(University of Oklahoma Health Sciences Center)
Cited by 58
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
|Clinical Cancer Research|2015|355